Logo

People in the News: Etienne Formstecher, Russell Golson, Lukas Reiter

Jan 11, 2014
Premium

Hybrigenics this week announced that it has appointed Etienne Formstecher CEO of its Hybrigenics Services subsidiary.

Formstecher was previously deputy general manager in charge of marketing, sales, and scientific projects at Hybrigenics Services. He originally joined the company in 2002.

Biognosys said this week that it has named Russell Golson as director of sales and Lukas Reiter as head of research and development.

Golson was previously CEO of BioSilta and sales director at Febit biotech. Reiter was previously Biognosys' head of bioinformatics.

Filed under

Proteomics & Protein Research
proteomics
Hybrigenics
Biognosys
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.